NeutralLOW severityEarnings27m ago

Biodesix expects $101M-$103M 2026 revenue while planning to exit 2026 with ~115 sales reps

Biodesix expects $101M-$103M 2026 revenue while planning to exit 2026 with ~115 sales reps — $BDSX one-month chart
$BDSX daily closes over the past month · Wook of Wall Street artwork from market data
WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about BDSX. Get explanations, comparisons and calculations with the source lookups shown.

Wook analysis

What it means

Key points
  • What to watch: Earnings season is a grading curve: the result is judged against the estimate, and the outlook against the hope.
  • How the stock is trading: $BDSX -7.68% in the latest session.
  • Timing: It landed while New York slept, so the session change beside it belongs to a day that had already closed. Market holidays are not detected.
Amount$101 million
Amount$103 million

Where the stock stands

$BDSX last changed hands at $19.84, -7.68% on the session, 38% below its 52-week high of $31.97 and 277% above its low of $5.26 — around the middle of the range. Over the year it has ranged 508% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $BDSX page.

How much coverage it is getting

Wook has logged 2 stories on $BDSX in the last 30 days, 2 of them this week. At its 30-day pace you would expect less than one a week, so this week is running well ahead of normal; the press has found a reason to keep writing. Across those stories 0 read bullish, 1 neutral and 1 bearish. This one reads neutral, so it sits in step with most of the run. 2 of the 2 (100%) came from Seeking Alpha itself, so the count says as much about how often Seeking Alpha hits publish as about how much attention there is — the other outlets are the better gauge. 12 related stories from the same name or desk are listed beside this one.

The bigger picture

With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. On Wook's supply-chain scanner, Health Care reads watch today — early signs of strain worth keeping an eye on.

What to watch next

For the receipts, the $BDSX page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $BDSX sits from its high, or how this week's coverage stacks up.

How this analysis was made

Seeking Alpha published it, and Wook filed it under Earnings. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $BDSX. It carried $101 million and $103 million, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.

The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.

Discussion

No one has weighed in yet. Start the discussion on this story.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what this browser shares. Essential sign-in and security cookies stay on.

Read the privacy policy